The Glutaraldehyde market size is forecast to reach US$252.3 million by 2027, after growing at a CAGR of 4.6% during 2022-2027. Glutaraldehyde is a colorless, oily liquid with a strong odor that is available as an aqueous solution that sterilizes and preserves. This aldehyde. Glutaraldehyde is biodegradable, formaldehyde-free, non-carcinogenic, non-bio-accumulative, non-persistent, and effective against a range of microorganisms. Due to these properties, its demand is accelerating applications such as high-level disinfection of surgical instruments and water treatments. Also, the market is being spurred by factors such as the growing healthcare industry in emerging economies, increasing demand for personal care and hygiene products, and the growing use of glutaraldehyde disinfectant in wastewater treatment applications. Furthermore, it is projected that the bolstering household and industrial cleaning industry will also contribute to glutaraldehyde market growth during the forecast period.
In 2020, the spread of COVID-19 rapidly advanced into a pandemic case, causing significant disturbances in health care systems. Disinfectants are essential preventive agents against the coronavirus disease, due to which there was an increasing demand for cleaned and sanitized surgical instruments in healthcare industries, to keep premises in check. Thus, the demand for glutaraldehyde disinfectants was in a constant path in the last few months of 2020 and starting of 2021. However, owing to the pandemic the water treatment and pipelines projects were on a halt to attain proper social distancing, which as result decreased the demand for glutaraldehyde. For instance, in December 2020, health professionals joined environmental advocacy groups and several tribal governments in a request to halt building Enbridge’s Line 3 pipeline replacement 337 miles across northern Minnesota, not only because an influx of 4,000 workers living in close quarters increases the risk of COVID-19 spread, but also because the health-care infrastructure across the pipeline’s path is already nearing its capacity. Thus, the glutaraldehyde market was partially affected due to the covid outbreak.
The report: “Glutaraldehyde Market - Forecast (2022-2027)” covers an in-depth analysis of the following segments of the Glutaraldehyde market.
Asia-Pacific dominates the glutaraldehyde market owing to the increasing hospital industry in the region. For instance, according to Invest India, the Indian hospital industry is expected to reach US$132 billion by 2023 from US$61.8 billion in 2017.
As it has a long history of successful industrial use and is backed by substantial efficacy, environmental, and safety data, glutaraldehyde is a very effective, broad-spectrum antibacterial for water treatment applications.
The majority of medically invasive procedures necessitate equipment sterilization to minimize infection from contaminated equipment. As a result, glutaraldehyde disinfectant is widely utilized in the healthcare industry to cold sterilize equipment before surgery.
Furthermore, increasing government investments in the oil & gas pipeline projects are expected to augment the product demand in near future.
The drum segment held a significant share in the Glutaraldehyde market in 2020 and is estimated to grow at a CAGR of 4.2% during 2022-2027. Drums such as plastic drums, steel drums, and Fibre drums are an excellent way to store and transport glutaraldehyde. Bottles and bags are less suitable for storing or transporting toxic or hazardous substances, and since Glutaraldehyde is hazardous, often steel and plastic drums are used for its packaging. Steel drums are an ideal choice for storing and transporting bulk quantities of glutaraldehyde due to their versatile design. They can also be easily palletized and wrapped, making them an ideal choice for glutaraldehyde bulk shipping applications. All of these perks of using plastic, steel, and fiber drums as packaging are gaining traction for glutaraldehyde packaging.
The disinfectant segment held a significant share in the glutaraldehyde market in 2020 and is forecasted to grow at a CAGR of 5.4% during 2022-2027. Glutaraldehyde is a saturated dialdehyde that has found extensive application in high concentrations as a disinfectant and chemical sterilant. One glutaraldehyde-based product has a high-level disinfection claim of 5 minutes at 35°C, according to the Centers for Disease Control and Prevention (CDC). Glutaraldehyde has long been used as a high-level disinfectant. It's used as a disinfectant to kill hazardous microbes on surgical tools, and it's also utilized as a fixative or preservative in other parts of a hospital. Furthermore, metals are not corroded by glutaraldehyde, and it does not harm lenses, rubber, or plastics, owing to which it is preferred over other disinfectants in various end-use industries. Thus, due to all these factors, the demand for glutaraldehyde as a disinfectant is increasing in various end-use industries.
The medical & healthcare segment held the largest share in the glutaraldehyde market in 2020 and is forecasted to grow at a CAGR of 6.1% during 2022-2027. Glutaraldehyde-based solutions are widely used in medical facilities due to several advantages, which include excellent biocidal properties, function in the presence of organic matter (20 percent bovine serum), and noncorrosive activity on endoscopic equipment, thermometers, rubber, or plastic equipment. Glutaraldehyde is used most commonly as a high-level disinfectant for medical equipment such as spirometry tubing, surgical instruments, transducers, endoscopes, dialyzers, dialysate delivery systems, hemodialysis proportioning, anesthesia therapy equipment, and laparoscopic disposable plastic trocars. Glutaraldehyde is also used as a tissue fixative in pathology labs, a hardening agent used to develop X-rays and for the preparation of grafts in the medical & healthcare sector. Thus, the wide application of glutaraldehyde in the medical & healthcare sector is the major factor driving its demand in the industry.
The Asia-Pacific region held the largest share in the glutaraldehyde market in 2020 up to 31%. The medical & healthcare industry is flourishing in the region, which is accelerating the demand for glutaraldehyde in the region. The medical & healthcare industry is flourishing in the region due to the densely populated countries such as India and China, the rising income level of the population, and increasing expenditure on healthcare facilities. The Indian government announced a budget for the health sector of Rs. 69,000 crore (US$9.87 billion) in January 2021, including Rs. 6,400 crores (US$915.72 million) for the PM AtmaNirbhar Swasth Bharat Yojana in the 2020-21 Union Budget. The Indian government wants to increase healthcare spending to 3% of GDP by 2022. (GDP). In March 2020, the Japanese government approved the second phase of its five-year health and medical plan. Also, the Japanese healthcare sector market is expected to grow to Yen33 trillion (US$300 billion) in 2025, up from Yen25 trillion (US$227 billion) in 2016. This is due to increased demand for prevention, health management, life support facilities, and developments in health services using emerging technologies such as digital health and genomic analysis. Thus, the growth in the Asia-Pacific medical & healthcare sector is accelerating the demand for glutaraldehyde in the region, thereby driving the market growth.
Biofilms are a major issue in oil and gas production systems, and biofilm-related issues are common in pipelines. The presence of a biofilm is frequently linked to microbiologically influenced corrosion (MIC). Controlling biofilms is therefore critical for minimizing corrosion events caused by microorganisms. Glutaraldehyde has been shown to perforate biofilms and kill the microorganisms within them. Because of its penetrating ability and long-term stability in oilfield waters, glutaraldehyde is an effective product for controlling existing biofilms in pipelines and preventing the formation of new ones. And governments are investing extensively in pipeline projects. For instance, the Indian government aims to create natural gas infrastructure in India with an investment of US$60 billion through 2024 which includes laying gas pipelines and LNG terminals. In April 2018, the European Council proposed building a 159-kilometer bidirectional pipeline connecting Malta and Italy. Malta decided in July 2019 to fund the entire €400 million (US$440 million) project, which is expected to be completed in 2024. Thus, it is anticipated that the increasing pipeline projects will drive the glutaraldehyde market in the future.
Glutaraldehyde is used in the treatment of cooling water, wastewater, process water systems, and reverse osmosis (RO) membranes. Glutaraldehyde is typically dosed at concentrations of 20-100 ppm active ingredient in water treatment systems, and it can be used in slug or continuous dosing. Some applications, like RO membrane remediation and wastewater treatment, have broader label limits and permit higher dosing. The water treatment projects are on an upsurge. For instance, the North Shore Wastewater Treatment Plant Construction is currently underway and is anticipated to be complete and fully operational in 2024. In Amy 2021, The Emirates Water and Electricity Company (EWEC) has announced plans to invest heavily in RO desalination capacity. The plans call for a new capacity capable of producing 170 million gallons per day (772,820 m3/day) of drinking water, to meet a good portion of its ambitious sustainability plans through RO alone. The new RO facilities will be installed over the next few years, with the majority of them being in Abu Dhabi and neighboring emirates. With the increasing water treatment projects, the demand for glufosinate will also significantly increase, which will certainly drive the market growth during the forecast period.
In the industrial, scientific, and biomedical fields, glutaraldehyde (GA) is widely used. Many negative health effects in humans have been linked to biomedical uses of GA, with 2-3.5 percent aqueous GA solution commonly used for cold sterilization and GA exposure levels ranging from 0.001 to 2.6 ppm. GA is extensively metabolized to CO(2), but urinary excretion is low. Endoscopy nurses and medical radiation technologists have reported sensory irritant effects, sensitization of skin and respiratory organs, and other symptoms. The prevalence of chronic bronchitis and nasal symptoms in humans is strongly linked to GA exposure peak concentrations. The severity of primary skin irritation is dose-dependent and depends on the duration and location of contact. In addition, chronic inhalation of glutaraldehyde causes damage to the nose and respiratory tract, with lesions becoming more severe with time. In March 2021, the European Commission announced its plan to push through a proposal to add glutaraldehyde to the REACH Directive's list of substances of very high concern (SVHC), which includes its use in tanning chemicals. Thus, these acute hazards related to glutaraldehyde are posing a significant challenge for the glutaraldehyde market.
2. Grassland Agro
3. Advanced Sterilization Products (Cilag GmbH International)
4. Whiteley Corporation
5. Sisco Research Laboratories Pvt. Ltd.
6. Lenntech B.V.
7. The Dow Chemical Company
8. Hubei Jinghong Chemical Co., Ltd.
9. Evans Vanodine International PLC
10. Finoric LLC
In August 2021, Lanxess has agreed to pay $1.3 billion for the microbial control business of International Flavors & Fragrances. Lanxess will gain a producer of glutaraldehyde, a biocide used in preservative applications such as paints, home, and personal care products, and oil and gas drilling, as part of the deal, which is expected to be completed by mid-2021.
This product will be delivered within 2 business days.
COVID-19 Impact
In 2020, the spread of COVID-19 rapidly advanced into a pandemic case, causing significant disturbances in health care systems. Disinfectants are essential preventive agents against the coronavirus disease, due to which there was an increasing demand for cleaned and sanitized surgical instruments in healthcare industries, to keep premises in check. Thus, the demand for glutaraldehyde disinfectants was in a constant path in the last few months of 2020 and starting of 2021. However, owing to the pandemic the water treatment and pipelines projects were on a halt to attain proper social distancing, which as result decreased the demand for glutaraldehyde. For instance, in December 2020, health professionals joined environmental advocacy groups and several tribal governments in a request to halt building Enbridge’s Line 3 pipeline replacement 337 miles across northern Minnesota, not only because an influx of 4,000 workers living in close quarters increases the risk of COVID-19 spread, but also because the health-care infrastructure across the pipeline’s path is already nearing its capacity. Thus, the glutaraldehyde market was partially affected due to the covid outbreak.
Report Coverage
The report: “Glutaraldehyde Market - Forecast (2022-2027)” covers an in-depth analysis of the following segments of the Glutaraldehyde market.
- By Type: Glutaraldehyde 50%, and Glutaraldehyde 25%
- By Purity: Less than 98% and More than 99%
- By Packaging: Pail, Drums, Bags, and Others
- By Application: Disinfectant, Cross-linking Agent, Tanning Agent, Preservative, Fixative, Biocide, and Others
- By End-Use Industry: Water Treatment (Wastewater, and Drinking Water), Medical & Healthcare (Medical Equipment, and Medical Devices), Personal Care & Cosmetics (Bath Products, Cleansing Products, and Hair Products), Metalworking, Cleaning (Household, and Industrial), Oil & Gas (Production Wells, Pipelines, and Drilling), Leather, Agriculture, Paper & Pulp, and Others
- By Geography: North America (USA, Canada, and Mexico), Europe (UK, Germany, France, Italy, Netherlands, Spain, Russia, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia and New Zealand, Indonesia, Taiwan, Malaysia, and Rest of APAC), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), Rest of the World (the Middle East, and Africa)
Key Takeaways
Asia-Pacific dominates the glutaraldehyde market owing to the increasing hospital industry in the region. For instance, according to Invest India, the Indian hospital industry is expected to reach US$132 billion by 2023 from US$61.8 billion in 2017.
As it has a long history of successful industrial use and is backed by substantial efficacy, environmental, and safety data, glutaraldehyde is a very effective, broad-spectrum antibacterial for water treatment applications.
The majority of medically invasive procedures necessitate equipment sterilization to minimize infection from contaminated equipment. As a result, glutaraldehyde disinfectant is widely utilized in the healthcare industry to cold sterilize equipment before surgery.
Furthermore, increasing government investments in the oil & gas pipeline projects are expected to augment the product demand in near future.
Glutaraldehyde Market Segment Analysis - By Packaging
The drum segment held a significant share in the Glutaraldehyde market in 2020 and is estimated to grow at a CAGR of 4.2% during 2022-2027. Drums such as plastic drums, steel drums, and Fibre drums are an excellent way to store and transport glutaraldehyde. Bottles and bags are less suitable for storing or transporting toxic or hazardous substances, and since Glutaraldehyde is hazardous, often steel and plastic drums are used for its packaging. Steel drums are an ideal choice for storing and transporting bulk quantities of glutaraldehyde due to their versatile design. They can also be easily palletized and wrapped, making them an ideal choice for glutaraldehyde bulk shipping applications. All of these perks of using plastic, steel, and fiber drums as packaging are gaining traction for glutaraldehyde packaging.
Glutaraldehyde Market Segment Analysis - By Application
The disinfectant segment held a significant share in the glutaraldehyde market in 2020 and is forecasted to grow at a CAGR of 5.4% during 2022-2027. Glutaraldehyde is a saturated dialdehyde that has found extensive application in high concentrations as a disinfectant and chemical sterilant. One glutaraldehyde-based product has a high-level disinfection claim of 5 minutes at 35°C, according to the Centers for Disease Control and Prevention (CDC). Glutaraldehyde has long been used as a high-level disinfectant. It's used as a disinfectant to kill hazardous microbes on surgical tools, and it's also utilized as a fixative or preservative in other parts of a hospital. Furthermore, metals are not corroded by glutaraldehyde, and it does not harm lenses, rubber, or plastics, owing to which it is preferred over other disinfectants in various end-use industries. Thus, due to all these factors, the demand for glutaraldehyde as a disinfectant is increasing in various end-use industries.
Glutaraldehyde Market Segment Analysis - By End-Use Industry
The medical & healthcare segment held the largest share in the glutaraldehyde market in 2020 and is forecasted to grow at a CAGR of 6.1% during 2022-2027. Glutaraldehyde-based solutions are widely used in medical facilities due to several advantages, which include excellent biocidal properties, function in the presence of organic matter (20 percent bovine serum), and noncorrosive activity on endoscopic equipment, thermometers, rubber, or plastic equipment. Glutaraldehyde is used most commonly as a high-level disinfectant for medical equipment such as spirometry tubing, surgical instruments, transducers, endoscopes, dialyzers, dialysate delivery systems, hemodialysis proportioning, anesthesia therapy equipment, and laparoscopic disposable plastic trocars. Glutaraldehyde is also used as a tissue fixative in pathology labs, a hardening agent used to develop X-rays and for the preparation of grafts in the medical & healthcare sector. Thus, the wide application of glutaraldehyde in the medical & healthcare sector is the major factor driving its demand in the industry.
Glutaraldehyde Market Segment Analysis - By Geography
The Asia-Pacific region held the largest share in the glutaraldehyde market in 2020 up to 31%. The medical & healthcare industry is flourishing in the region, which is accelerating the demand for glutaraldehyde in the region. The medical & healthcare industry is flourishing in the region due to the densely populated countries such as India and China, the rising income level of the population, and increasing expenditure on healthcare facilities. The Indian government announced a budget for the health sector of Rs. 69,000 crore (US$9.87 billion) in January 2021, including Rs. 6,400 crores (US$915.72 million) for the PM AtmaNirbhar Swasth Bharat Yojana in the 2020-21 Union Budget. The Indian government wants to increase healthcare spending to 3% of GDP by 2022. (GDP). In March 2020, the Japanese government approved the second phase of its five-year health and medical plan. Also, the Japanese healthcare sector market is expected to grow to Yen33 trillion (US$300 billion) in 2025, up from Yen25 trillion (US$227 billion) in 2016. This is due to increased demand for prevention, health management, life support facilities, and developments in health services using emerging technologies such as digital health and genomic analysis. Thus, the growth in the Asia-Pacific medical & healthcare sector is accelerating the demand for glutaraldehyde in the region, thereby driving the market growth.
Glutaraldehyde Market Drivers
Accelerating Pipeline Infrastructure
Biofilms are a major issue in oil and gas production systems, and biofilm-related issues are common in pipelines. The presence of a biofilm is frequently linked to microbiologically influenced corrosion (MIC). Controlling biofilms is therefore critical for minimizing corrosion events caused by microorganisms. Glutaraldehyde has been shown to perforate biofilms and kill the microorganisms within them. Because of its penetrating ability and long-term stability in oilfield waters, glutaraldehyde is an effective product for controlling existing biofilms in pipelines and preventing the formation of new ones. And governments are investing extensively in pipeline projects. For instance, the Indian government aims to create natural gas infrastructure in India with an investment of US$60 billion through 2024 which includes laying gas pipelines and LNG terminals. In April 2018, the European Council proposed building a 159-kilometer bidirectional pipeline connecting Malta and Italy. Malta decided in July 2019 to fund the entire €400 million (US$440 million) project, which is expected to be completed in 2024. Thus, it is anticipated that the increasing pipeline projects will drive the glutaraldehyde market in the future.
Increasing Water Treatment Projects
Glutaraldehyde is used in the treatment of cooling water, wastewater, process water systems, and reverse osmosis (RO) membranes. Glutaraldehyde is typically dosed at concentrations of 20-100 ppm active ingredient in water treatment systems, and it can be used in slug or continuous dosing. Some applications, like RO membrane remediation and wastewater treatment, have broader label limits and permit higher dosing. The water treatment projects are on an upsurge. For instance, the North Shore Wastewater Treatment Plant Construction is currently underway and is anticipated to be complete and fully operational in 2024. In Amy 2021, The Emirates Water and Electricity Company (EWEC) has announced plans to invest heavily in RO desalination capacity. The plans call for a new capacity capable of producing 170 million gallons per day (772,820 m3/day) of drinking water, to meet a good portion of its ambitious sustainability plans through RO alone. The new RO facilities will be installed over the next few years, with the majority of them being in Abu Dhabi and neighboring emirates. With the increasing water treatment projects, the demand for glufosinate will also significantly increase, which will certainly drive the market growth during the forecast period.
Glutaraldehyde Market Challenges
Acute Hazards Related to Glutaraldehyde
In the industrial, scientific, and biomedical fields, glutaraldehyde (GA) is widely used. Many negative health effects in humans have been linked to biomedical uses of GA, with 2-3.5 percent aqueous GA solution commonly used for cold sterilization and GA exposure levels ranging from 0.001 to 2.6 ppm. GA is extensively metabolized to CO(2), but urinary excretion is low. Endoscopy nurses and medical radiation technologists have reported sensory irritant effects, sensitization of skin and respiratory organs, and other symptoms. The prevalence of chronic bronchitis and nasal symptoms in humans is strongly linked to GA exposure peak concentrations. The severity of primary skin irritation is dose-dependent and depends on the duration and location of contact. In addition, chronic inhalation of glutaraldehyde causes damage to the nose and respiratory tract, with lesions becoming more severe with time. In March 2021, the European Commission announced its plan to push through a proposal to add glutaraldehyde to the REACH Directive's list of substances of very high concern (SVHC), which includes its use in tanning chemicals. Thus, these acute hazards related to glutaraldehyde are posing a significant challenge for the glutaraldehyde market.
Glutaraldehyde Market Landscape
Technology launches, acquisitions, and R&D activities are key strategies adopted by players in the Glutaraldehyde market. Glutaraldehyde market top companies include:
1. Universal Preserv-A-Chem Inc. (UPICHEM)2. Grassland Agro
3. Advanced Sterilization Products (Cilag GmbH International)
4. Whiteley Corporation
5. Sisco Research Laboratories Pvt. Ltd.
6. Lenntech B.V.
7. The Dow Chemical Company
8. Hubei Jinghong Chemical Co., Ltd.
9. Evans Vanodine International PLC
10. Finoric LLC
Acquisitions/Technology/Product Launches
In August 2021, Lanxess has agreed to pay $1.3 billion for the microbial control business of International Flavors & Fragrances. Lanxess will gain a producer of glutaraldehyde, a biocide used in preservative applications such as paints, home, and personal care products, and oil and gas drilling, as part of the deal, which is expected to be completed by mid-2021.
This product will be delivered within 2 business days.
Table of Contents
1. Glutaraldehyde Market- Market Overview
2. Glutaraldehyde Market- Executive Summary
3. Glutaraldehyde Market - Comparative analysis
4. Glutaraldehyde Market - Market Forces
5. Glutaraldehyde Market - Strategic Analysis
6. Glutaraldehyde Market - By Type (Market Size -US$ Million/Billion)
7. Glutaraldehyde Market - By Purity (Market Size -US$ Million/Billion)
8. Glutaraldehyde Market - By Packaging (Market Size -US$ Million/Billion)
9. Glutaraldehyde Market - By Application (Market Size -US$ Million/Billion)
10. Glutaraldehyde Market - By End-Use Industry (Market Size -US$ Million/Billion)
11. Glutaraldehyde Market - By Geography (Market Size -US$ Million/Billion)
12. Glutaraldehyde Market - Entropy
13. Glutaraldehyde Market Company Analysis - Business Overview, Product Portfolio, Financials, and Developments
Methodology
LOADING...
